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Using chromatography on a Fast S-Sepharose column, the insulin-stimulated S6 kinase can be resolved from other S6 
kinases present in 3T3 Ll cell extracts. Only one S6 kinase is greatly activated by insulin (45-fold) and phosphorylates 
S6 with a high stoichiometry (4-5 mol phosphate per mol S6). This insulin-dependent S6 kinase can be activated in cell- 
free extracts by incubation with high concentrations of Ca 2+ This activation is blocked by protease inhibitors such as . 
leupeptin and is mimicked by trypsin. The stimulation does not require the presence of the protein kinase dependent 
on phospholipids and calcium (PK-C) in the cell extracts. The level of stimulation produced by proteolysis in the cell 
extracts is comparable to that reached in vivo by incubation with insulin. 
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1. INTRODUCTION 
Insulin and other growth factors promote the ac- 
tivation of a soluble S6 kinase present in the cytosol 
of 3T3 Ll cells and other cell lines [l-5]. This 
mitogen-activated S6 kinase shows an absolute 
specificity for S6 and incorporates up to 4-5 mol 
phosphate per mol S6, the same stoichiometry as 
that observed in intact cells treated with insulin [6]. 
S6 can also be phosphorylated ‘in vitro’ by several 
histone kinases with lower stoichiometry [7-lo]. 
Complete purification of a mitogen-activated S6 
kinase has been recently reported from different 
sources [ 1 l-141. This S6 kinase is regulated by 
phosphorylation-dephosphorylation; treatment 
with phosphatase 2A inactivates the enzyme 
[14-161 whereas another protein kinase, MAP-2 
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kinase, can phosphorylate and reactivate the S6 
kinase [16]. 
Here, I report that an S6 kinase can be activated 
in cell-free extracts by a calcium-dependent pro- 
tease or by trypsin. This kinase has been identified 
as the insulin-stimulated S6 kinase according to its 
specificity, high stoichiometry of phosphorylation 
and behaviour on columns of Fast S-Sepharose. 
2. MATERIALS AND METHODS 
Histones and casein were from Sigma. All resins were from 
Pharmacia. The 40 S ribosomal subunits were prepared accor- 
ding to [17]. Protein kinase M, the catalytically active pro- 
teolytic fragment of protein kinase C, was prepared as in [18] 
from purified PK-C [7]. Protein kinase assays were performed 
as in [2] with 0.5 mg/ml40 S ribosomal subunits, 0.5 mg/ml ca- 
sein or 0.4 mg/ml histone as substrates. Two-dimensional gel 
electrophoresis was carried out as in [12]. Proteins were deter- 
mined with the BCA kit from Pierce using serum albumin as 
standard. Preparation of the 3T3 Ll cell extract was performed 
as described [2] using 25 mM Hepes, pH 7.5, 1 mM EOTA as 
homogenization buffer. 
3. RESULTS AND DISCUSSION 
The insulin-stimulated S6 kinase can be easily 
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resolved from other S6 kinases present in 3T3 Ll 
cell extracts via chromatography on Fast S- 
Sepharose or Mono S columns. When a high-speed 
supernatant was loaded on a Mono S column, more 
than 90% of the total S6 kinase activity was retain- 
ed in the column (fig.1). This kinase activity elutes 
in two well-defined peaks with different properties. 
The first, eluting at 170 mM KC1 (peak I), is very 
strongly stimulated with insulin and constitutes 
30-50% of the total S6 kinase in extracts from 
insulin-treated cells. The second (eluting at 
260 mM KCl, peak II) is the major S6 kinase found 
in control cells and is very slightly increased by in- 
sulin (20-50%). Similar increases were noted in ex- 
tracts of cells treated with the phorbol ester TPA 
(fig. 1). Neither form exhibits histone kinase activi- 
ty nor is able to phosphorylate proteins other than 
S6 in the 40 S subunits. The stoichiometry of phos- 
phorylation of S6 by each peak is different. Peak II 
S6 kinase, similarly to CAMP-dependent kinase or 
PK-C, incorporates 2 mol phosphate per mol S6 
whereas the value for peak I can be up to 5 (not 
shown). The stability of the two forms is also dif- 
ferent. Incubation of an extract derived from 
insulin-treated cells at 30°C for 15 min produced a 
total loss in peak I S6 kinase and only a lo-20% 
decrease in peak II (not shown). The activity can be 
maintained in the presence of phosphatase in- 
hibitors such as p-nitrophenyl phosphate, sug- 
gesting the involvement of a phosphatase in deac- 
tivation, as described for the insulin-activated S6 
kinase [14-161. Peak II, but not peak I, copurifies 
on the Mono S column with a casein kinase activi- 
ty. The addition of excess casein to the S6 phos- 
phorylation assay abolishes completely the S6 
kinase activity present in peak II but does not af- 
fect the activity associated with peak I (not shown). 
Collectively, all these results (high stoichiometry 
of phosphorylation, specificity, low stability) sug- 
gest that peak I is the principal S6 kinase that is ac- 
tivated by insulin and responsible for complete 
phosphorylation of S6 following insulin addition 
to cells. Peak II corresponds to a casein kinase, 
probably casein kinase II that has been described as 
being increased by insulin treatment [191. 
Addition of Ca2+ (0.4-l .O mM) to a control cell 
extract promoted an increase in peak I S6 kinase 
(fig.2). This stimulation was prevented by the pro- 
tease inhibitor leupeptin (25 pg/ml) (table 1A). 
Like insulin or TPA (fig.l), incubation with Ca2+ 
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Fig.1. Separation of two forms of S6 kinase using 
chromatography on columns of S-Sepharose. High-speed super- 
natants (200 ~1, 1.3 mg protein) from TPA-treated (A), insulin- 
treated (B) or control cells (C) were filtered (Millipore HV) and 
injected into an FPLC Mono S column equilibrated in 25 mM 
Hepes (pH 7.5), 1 mM EGTA, 1 mM DTT and eluted with a 
gradient of 100-500 mM KC1 in this buffer. Aliquots (5 ~1) of 
each fraction were assayed for S6 kinase activity. Cells were 
treated with 200 nM TPA or 400 nM insulin for 60 min before 
preparation of extracts. 
12345 
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Fig.2. Increase in S6 kinase activity after incubation of cell ex- 
tracts with Ca’+. Extract (200 ,ul, 1.2 mg protein) from control 
cells was incubated with 1 mM CaCl2 (0) or 2 mM EGTA (0) 
for 15 min at 30°C. After addition of EGTA to neutralize the 
Ca*+, samples were loaded onto a column of Fast S-Sepharose 
(0.3 ml) equilibrated in buffer (25 mM Hepes, pH 7.5, 1 mM 
EGTA). The columns were washed with the same buffer plus 
0.1 M KC1 and the S6 kinases eluted successively with the buffer 
plus 0.2 and 0.3 M KCI. Arrows indicate the beginning of elu- 
tion with either 200 or 300 mM KCl. 
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Table 1 
Activation of insulin-dependent S6 kinase by incubation of cell extracts with Ca*+ or trypsin 
Additions 
(A) 
EGTA (2 mM) 
Ca2+ ( 5OpM) 
(100 PM) 
(400 cM) 
(1 mM) 
(1 mM) + leupeptin (25 pg/ml) 
Phosphorylation 
of S6 (pmol) 
0.9 
1.5 
1.8 
2.5 
2.7 
1.1 
Activation 
(070) 
66 
100 
178 
200 
22 
(E) 
EGTA (1 mM) 
+ trypsin (1 pg/mg extract protein) 
+ trypsin (3 pg/mg extract protein) 
1.0 
1.7 70 
2.4 140 
(C) 
(Control cell extract) 
EGTA (2 mM) 
+ PK-M (2000 IJ) 
Ca” (1 mM) 
1.5 
1.6 7 
4.7 213 
(PK-C depleted-cell extract) 
EGTA (2 mM) 1.7 
Ca*+ 4.9 188 
The activation reaction was performed by incubating cell extracts with the indicated additions 
in a final volume of 100 ~1 for 10 min at 30°C. After the reaction was terminated with EGTA 
or trypsin inhibitor, the S6 kinase was purified by chromatography on a Fast S-Sepharose 
column and the material eluting with 200 mM KC1 (peak I) assayed for S6 kinase activity. The 
depletion of PK-C in the cells of experiment C was carried out by adding 10 PM TPA to the 
cell medium 6 h before homogenization. After these treatments only 2.2% of the initial PK-C 
activity was detected in the cell extracts. One unit of PK-M activity was defined as 1 pmol ‘*P 
incorporated into histone per min 
stimulated peak I, but not peak II. This treatment 
also activated another S6 kinase which was not re- 
tained on S-Sepharose and phosphorylated histone 
and a 20 kDa 40 S ribosome-associated protein. In 
accordance with its properties, this latter kinase 
can tentatively be identified as PK-M (the 
catalytically active fragment of PK-C). Addition of 
trypsin to the extract (l-3 ,ug trypsin/mg extract 
protein for 15 min at 30°C) also activates the peak 
I S6 kinase (table 1B). 
Incubation of the extract with Ca*+ or trypsin 
also promoted disappearance of PK-C activity and 
generation of another histone kinase activity which 
behaved like PK-M upon chromatography on 
DEAE-cellulose. PK-C is a well-known substrate 
for a class of calcium-activated proteases (calpains) 
which convert it to PK-M [20]. This reaction is 
abrogated by leupeptin. Although it is possible that 
PK-M may phosphorylate and activate the insulin- 
stimulated S6 kinase, several ines of evidence sug- 
gest that this is unlikely. Firstly, addition of highly 
purified PK-M to a control cell extract, in the 
absence of Ca*+, did not activate the peak I S6 
kinase (table 1). Secondly, Ca*+-mediated S6 
kinase occurs with the same efficiency in PK-C- 
depleted extracts derived from cells exposed to 
10 FM TPA for 6 h. Such extracts contain less than 
3% of the PK-C activity present in control cells and 
exhibit very low basal S6 kinase activity. Cells 
treated in this manner with TPA are, however, sen- 
sitive to insulin-dependent S6 kinase activation 
[21]. Incubation of these extracts with Ca*+ pro- 
duces an increase in S6 kinase similar to that in 
control extracts (table 1C). No generation of PK-M 
was observed in these TPA-pretreated extracts. It is 
possible to conclude that insulin stimulates S6 
55 
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kinase via a mechanism that does not involve PK-C 
activation and that the Ca2+-dependent leupeptin- 
sensitive activation of S6 kinase in cell-free extracts 
is not mediated by either PK-C or PK-M. 
All of my attempts to reproduce the activation of 
S6 kinase by trypsin using cytosolic fractions have 
been unsuccessful. These results suggest hat pro- 
teolysis does not directly affect the insulin- 
stimulated S6 kinase but acts upon an effector of 
this activity. It is possible that this effector is the 
MAP-2 kinase that can phosphorylate the insulin- 
dependent S6 kinase and activate it [16]. In any 
case, this method of activation of this S6 kinase by 
proteolysis in vitro constitutes an easy and rapid 
way of determining the presence of the proenzyme 
in a cell extract. 
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